5-alpha-reductase deficiency cost-effectiveness of therapy

5-alpha-reductase deficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 5-alpha-reductase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Molecular Genetic Studies
Genotyping
Pelvic X Ray
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
5-alpha-reductase deficiency cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of 5-alpha-reductase deficiency cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on 5-alpha-reductase deficiency cost-effectiveness of therapy
CDC on 5-alpha-reductase deficiency cost-effectiveness of therapy
5-alpha-reductase deficiency cost-effectiveness of therapy in the news
Blogs on 5-alpha-reductase deficiency cost-effectiveness of therapy
Directions to Hospitals Treating 5-alpha-reductase deficiency
Risk calculators and risk factors for 5-alpha-reductase deficiency cost-effectiveness of therapy

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.